FDA Inspection 1181203 — Washington Hospital Center Transfusion Service
The FDA completed an inspection of Washington Hospital Center Transfusion Service on Sep 20, 2022 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 20, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Washington, DC (United States)